Amylyx Pharmaceuticals Inc (AMLX)
5.715
+0.08
(+1.33%)
USD |
NASDAQ |
Nov 04, 16:00
5.70
-0.02
(-0.26%)
After-Hours: 04:23
Amylyx Pharmaceuticals Shareholders Equity (Quarterly): 261.31M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 261.31M |
| March 31, 2024 | 324.44M |
| December 31, 2023 | 433.43M |
| September 30, 2023 | 418.40M |
| June 30, 2023 | 386.36M |
| March 31, 2023 | 352.65M |
| December 31, 2022 | 340.61M |
| Date | Value |
|---|---|
| September 30, 2022 | 144.03M |
| June 30, 2022 | 192.79M |
| March 31, 2022 | 240.95M |
| December 31, 2021 | -151.17M |
| September 30, 2021 | -124.07M |
| December 31, 2020 | -66.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-151.17M
Minimum
Dec 2021
433.43M
Maximum
Dec 2023
211.77M
Average
261.31M
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
| PTC Therapeutics Inc | -980.18M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 332.16M |
| Total Liabilities (Quarterly) | 70.85M |
| Current Ratio | 4.662 |